Some of the drugs used to treat HIV patients are competitive inhibitors of the HIV reverse transcriptase enzyme. Unfortunately, the high mutation rate of HIV means that the virus rapidly acquires mutations with amino acid changes that make them resistant to competitive inhibitors. If these drugs are competative inhibitors, where in the reverse transcriptase enzyme would such an amino acid change most likely occur in drug resistant viruses?